Top Stocks To Buy Today As Markets Trade Higher Despite Stimulus Criticism

Markets rose slightly despite President Donald Trump slamming the stimulus package in a late night video. The Dow Jones rose 200 points, while the S&P gained 0.5% and looked to end a 3-day losing streak. The Nasdaq also rose 0.1%. Late Tuesday night, President Trump called the $900 billion stimulus package an unsuitable “disgrace.” While the president did not explicitly threaten to veto the bill, he asked to be sent a “suitable bill or else the next administration will have to deliver a COVID relief package.” Meanwhile, cyclical sectors and travel stocks sharply recovered today. Energy and financials each rose more than 1% each, as materials and industrials also gained. United Airlines and Delta also gained more than 2% each, while Carnival rose over 4%, and Norwegian traded 3.7% higher. For investors looking to make the most of this market, the deep learning algorithms at Q.ai have crunched the data to give you a set of Top Buys. Our Artificial Intelligence (“AI”) systems assessed each firm on parameters of Technicals, Growth, Low Volatility Momentum, and Quality Value to find the best long plays.

Sign up for the free Forbes AI Investor newsletter here to join an exclusive AI investing community and get premium investing ideas before markets open.

Edison International (EIX)

Our first Top Buy today is Edison International (EIX). Edison International is a California-based public utility holding company with subsidiaries including companies such as Southern California Edison. Our AI systems rated Edison International B in Technicals, A in Growth, C in Low Volatility Momentum, and C in Quality Value. The stock closed down 0.9% to $61.32 on volume of 1,039,747 vs its 10-day price average of $62.59 and its 22-day price average of $62.65, and is down 14.62% for the year. Revenue grew by 8.46% in the last fiscal year and grew by 8.69% over the last three fiscal years, while Operating Income grew by 13.13% in the last fiscal year and grew by 23.94% over the last three fiscal years. Revenue was $12347.0M in the last fiscal year compared to $12320.0M three years ago, Operating Income was $2444.0M in the last fiscal year compared to $2231.0M three years ago, EPS was $3.77 in the last fiscal year compares to $1.72 three years ago, and ROE was 9.12% in the last year compared to 3.88% three years ago. The stock is also trading with a Forward 12M P/E of 13.39.

MORE FROM FORBESEdison International (EIX)

MORE FOR YOU

Lam Research Corp (LRCX)

Lam Research Corp is our next Top Buy today. Lam Research is a big player in the semiconductor space and operates in the design, manufacture, marketing, and service of semiconductor processing equipment used in the fabrication of integrated circuits. Our AI systems rated Lam Research C in Technicals, A in Growth, B in Low Volatility Momentum, and B in Quality Value. The stock closed down 1.3% to $476.95 on volume of 943,908 vs its 10-day price average of $488.36 and its 22-day price average of $477.57, and is up 62.55% for the year. Revenue grew by 10.07% in the last fiscal year, while Operating Income grew by 15.84% in the last fiscal year, and EPS grew by 16.55% in the last fiscal year and grew by 33.63% over the last three fiscal years. Revenue was $10044.74M in the last fiscal year compared to $11077.0M three years ago, Operating Income was $2673.8M in the last fiscal year compared to $3213.3M three years ago, EPS was $15.1 in the last fiscal year compared to $13.17 three years ago, and ROE was 45.74% in the last year compared to 35.75% three years ago. Forward 12M Revenue is expected to grow by 1.38% over the next 12 months, and the stock is trading with a Forward 12M P/E of 21.01.

MORE FROM FORBESLam Research (LRCX)

Marsh & McLennan Cos (MMC)

Marsh & McLennan Cos is our third Top Buy of the day. Marsh and McLennan is a worldwide leading professional services firm with businesses in insurance brokerage, risk management, reinsurance services, talent management, investment advisory, and management consulting. Our AI systems rated the company C in Technicals, B in Growth, B in Low Volatility Momentum, and A in Quality Value. The stock closed down 1.05% to $115.05 on volume of 1,491,054 vs its 10-day price average of $116.21 and its 22-day price average of $115.66, and is up 4.47% for the year. Revenue grew by 2.52% in the last fiscal year and grew by 21.73% over the last three fiscal years, Operating Income grew by 18.17% in the last fiscal year and grew by 40.76% over the last three fiscal years, and EPS grew by 16.72% in the last fiscal year and grew by 38.49% over the last three fiscal years. Revenue was $16652.0M in the last fiscal year compared to $14024.0M three years ago, Operating Income was $3402.0M in the last fiscal year compared to $2856.0M three years ago, EPS was $3.41 in the last fiscal year compared to $2.87 three years ago, and ROE was 22.84% in the last year compared to 22.02% three years ago. Forward 12M Revenue is expected to grow by 3.04% over the next 12 months, and the stock is trading with a Forward 12M P/E of 22.82.

MORE FROM FORBESMarsh & McLennan (MMC)

Pfizer Inc (PFE)

Pfizer is our third Top Buy today, and is on our list for the second day in a row. After announcing clinical results of its COVID vaccine on November 9th, Pfizer has almost single handedly spurred a major market rally and flickered on a light at the end of the pandemic tunnel. However, since its vaccine has begun its roll-out process, Pfizer’s stock has pulled back and may be at an attractive entry point. Although it will not be the only vaccine, and has witnessed some supply chain and distribution issues, it still remains one of the world’s largest pharmaceutical companies and a stable dividend payer. Our AI systems rated Pfizer C in Technicals, B in Growth, A in Momentum Volatility, and C in Quality Value. The stock closed down 1.71% to $36.74 on volume of 33,461,212 vs its 10-day price average of $39.03 and its 22-day price average of $38.94, and is up 3.09% for the year. Revenue was $51750.0M in the last fiscal year compared to $52546.0M three years ago, Operating Income was $15042.0M in the last fiscal year compared to $14711.0M three years ago, EPS was $2.87 in the last fiscal year compared to $3.52 three years ago, and ROE was 25.62% in the last year compared to 32.48% three years ago. The stock is also trading with a Forward 12M P/E of 13.03.

MORE FROM FORBESPfizer (PFE)

Primoris Services Corp (PRIM)

Primoris Services Corp is our fourth Top Buy today and on our list for the second time this week. Primoris Services is a construction and infrastructure company and focuses particularly on pipelines for natural gas, wastewater and water. Our AI systems rated the company B in Technicals, C in Growth, C in Low Volatility Momentum, and A in Quality Value. The stock closed up 1.42% to $27.76 on volume of 146,532 vs its 10-day price average of $27.42 and its 22-day price average of $26.25, and is up 29.36% for the year. Revenue grew by 8.94% in the last fiscal year and grew by 42.18% over the last three fiscal years, Operating Income grew by 13.92% in the last fiscal year and grew by 47.86% over the last three fiscal years, and EPS grew by 26.22% in the last fiscal year and grew by 45.16% over the last three fiscal years. Revenue was $3106.33M in the last fiscal year compared to $2380.0M three years ago, Operating Income was $140.88M in the last fiscal year compared to $108.54M three years ago, EPS was $1.61 in the last fiscal year compared to $1.4 three years ago, and ROE was 13.6% in the last year compared to 14.49% three years ago. Forward 12M Revenue is expected to grow by 1.48% over the next 12 months, and the stock is trading with a Forward 12M P/E of 13.95.

MORE FROM FORBESPrimoris Services (PRIM)

Snap-On Inc (SNA)

Snap-On Inc is our final Top Buy today. The company designs, manufactures, and markets high-end tools and equipment for use in the transportation industry. Our AI systems rated Snap-On Inc C in Technicals, C in Growth, B in Low Volatility Momentum, and B in Quality Value. The stock closed down 1.28% to $167.54 on volume of 367,421 vs its 10-day price average of $174.4 and its 22-day price average of $175.95, and is up 2.06% for the year. EPS grew by 12.34% over the last three fiscal years. Revenue was $4067.7M in the last fiscal year compared to $4000.3M three years ago, Operating Income was $960.8M in the last fiscal year compared to $881.2M three years ago, EPS was $12.41 in the last fiscal year compared to $9.52 three years ago, and ROE was 21.72% in the last year compared to 20.41% three years ago. Forward 12M Revenue is expected to grow by 4.52% over the next 12 months, and the stock is trading with a Forward 12M P/E of 14.89. 

MORE FROM FORBESSnap-on (SNA)

Liked what you read? Sign up for our free Forbes AI Investor Newsletter here to get AI driven investing ideas weekly. For a limited time, subscribers can join an exclusive slack group to get these ideas before markets open.

Comments are closed.